ArticleFrontiers in microbiology2022

Identification of Hypericin as a Candidate Repurposed Therapeutic Agent for COVID-19 and Its Potential Anti-SARS-CoV-2 Activity.

Aline da Rocha Matos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.